IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-in-Class DLL3 TOP1 ADC, in Small Cell Lung Cancer at the IASLC 2025 World Conference on Lung Cancer
80.0% (8/10) ORR and 70.0% (7/10) confirmed ORR in 2L SCLC; a 73.7% (14/19) ORR and 57.9% (11/19) confirmed ORR (1 pending confirmation) were observed across all lines of SCLC at the 2.4 mg/kg expansion dose of IDE849 77.1% (27/35) ORR and 60.0% (21/35) confirmed ORR (4 pending confirmation) in 2L SCLC; a 73.2% (52/71) […]
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Compass Minerals International Inc. Securities – CMP
KANSAS CITY, Kan., Sept. 7, 2025 /PRNewswire/ — The Rosen Law Firm, P.A. announces that the United States District Court for the District of Kansas has approved the following announcement of a proposed class action settlement that would benefit purchasers of Compass Minerals International Inc. securities (NYSE: CMP): UNITED STATES DISTRICT COURT DISTRICT OF KANSAS JOHN […]
Ivonescimab Plus Chemotherapy Demonstrates Consistent Global Benefit: HARMONi Data Update Shows OS HR=0.78, Nominal P=0.0332
The overall survival (OS) hazard ratio (HR) in the HARMONi trial was 0.78, with a nominal p-value of 0.0332 In the North American patients, the OS HR was 0.70 The HARMONi trial has already demonstrated clinically meaningful and statistically significant progression-free survival (PFS) outcomes In the HARMONi trial, clinical endpoint benefits, including OS and PFS, […]
20TH ANNUAL SURF DOG SURF-A-THON IS READY TO MAKE A SPLASH
Helen Woodward Animal Center’s Most PAWsome Fundraiser Makes Waves for Orphan Pets RANCHO SANTA FE, Calif., Sept. 7, 2025 /PRNewswire/ — Surf’s PUP! The highly-anticipated, longest-running, doggie surf competition is back on the beach, raising life-saving funds for orphan pets at Helen Woodward Animal Center. This morning, SurFURS and gromMUTTs are set to dive into action and […]
Global South media, think tank forum opens in southwest China’s Yunnan
KUNMING, China, Sept. 7, 2025 /PRNewswire/ — The 2025 Global South Media and Think Tank Forum opened Saturday in Kunming, capital of southwest China’s Yunnan Province. The event has gathered around 500 participants from more than 260 media outlets, think tanks, government agencies and international organizations across 110 countries and regions. Continue Reading Fu Hua, […]
Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025
Rolling NDA submission for zidesamtinib in TKI pre-treated advanced ROS1-positive NSCLC initiated under FDA’s RTOR program, with completion on track for the third quarter of 2025 CAMBRIDGE, Mass., Sept. 7, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today presented pivotal data […]
La série primée AquaSense 2 de Beatbot occupe le devant de la scène à l’IFA 2025
BERLIN, 7 septembre 2025 /PRNewswire/ — Beatbot, leader mondial de la technologie de nettoyage des piscines, annonce aujourd’hui son showcase de la série AquaSense 2 à l’IFA 2025, qui se tient à Berlin du 5 au 9 septembre. Les visiteurs peuvent découvrir l’ensemble de la série AquaSense 2 sur le stand Beatbot, hall 9, stand […]
Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer
Chemotherapy-free combination regimen ushers in new era for first-line treatment, with overall survival projected to exceed four years, surpassing monotherapy TKI osimertinib by more than one year RARITAN, N.J., Sept. 7, 2025 /PR Newswire/ – Johnson & Johnson (NYSE: JNJ) today announced The New England Journal of Medicine (NEJM) published results from the Phase 3 MARIPOSA […]
La pluripremiata serie AquaSense 2 è protagonista a IFA 2025 con Beatbot
BERLINO, 7 settembre 2025 /PRNewswire/ — Beatbot, leader mondiale nell’innovativa tecnologia per la pulizia delle piscine, ha annunciato oggi la presentazione della serie AquaSense 2 all’edizione di IFA 2025, tenutasi a Berlino dal 5 al 9 settembre. I visitatori potranno scoprire l’intera serie AquaSense 2 presso lo stand Beatbot nella hall 9, allo stand 138. […]
Die preisgekrönte AquaSense 2 Serie steht auf der IFA 2025 mit Beatbot im Mittelpunkt
BERLIN, 7. September 2025 /PRNewswire/ — Beatbot, ein weltweit führender Anbieter von innovativer Poolreinigungstechnologie, hat heute die Präsentation der AquaSense 2 Serie auf der IFA 2025 bekannt gegeben, die vom 5. bis 9. September in Berlin stattfindet. Besucher können die gesamte AquaSense 2 Serie auf dem Beatbot-Stand in Halle 9, Stand 138 erkunden. Continue Reading […]